Abstract
Cancer genomics, which deals with the study of the sum of DNA sequence and differences in patterns of gene expression between cancerous cells and healthy cells, helps to unfold the genetic origin and evolution of cancer genome, ultimately creating new therapeutic interventions. The era of cancer genome will take advantage of P4 medicine to quantify wellness and demystify disease. Future advancements in this field will follow extensive genetic testing, helping scientists to prepare drugs directly targeting those changes causing cancer. The ultimate goal is to provide proper treatment with precise dose—having negligible or no toxicity—for the specific patient to meet the need of the hour.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
AdvaMedDx (n.d.) The value of molecular diagnostics: advancing cancer treatment and care [online]. Available: https://www.advamed.org/sites/default/files/valuemoleculardiagnostics1.pdf (Accessed January 10, 2019)
Arnold M, Sierra MS, Laversanne M, Soerjomataram I, Jemal A, Bray F (2017) Global patterns and trends in colorectal cancer incidence and mortality. Gut 66(4):683–691
Burtis CA, Bruns DE (2014) Tietz fundamentals of clinical chemistry and molecular diagnostics-e-book, 7th edn. Elsevier Health Sciences
Cheng T, Zhan X (2017) Pattern recognition for predictive, preventive, and personalised medicine in cancer. EPMA J 8(1):51–60
Cheong SC, Vatanasapt P, Yi-Hsin Y, Zain RB, Kerr AR, Johnson NW (2017) Oral cancer in South East Asia: current status and future directions. Transl Res Oral Oncol 2:2057178X17702921
Choudhury JH, Ghosh SK (2015a) Promoter hypermethylation profiling identifies subtypes of head and neck cancer with distinct viral, environmental, genetic and survival characteristics. PLoS One 10(6):e0129808
Choudhury JH, Ghosh SK (2015b) Gene–environment interaction and susceptibility in head and neck cancer patients and in their first-degree relatives: a study of N ortheast I ndian population. J Oral Pathol Med 44(7):495–501
Choudhury JH, Singh SA, Kundu S, Choudhury B, Talukdar FR, Srivasta S, Laskar RS, Dhar B, Das R, Laskar S, Kumar M (2015) Tobacco carcinogen-metabolising genes CYP1A1, GSTM1, and GSTT1 polymorphisms and their interaction with tobacco exposure influence the risk of head and neck cancer in northeast Indian population. Tumour Biol 36(8):5773–5783
Collins A, Politopoulos I (2011) The genetics of breast cancer: risk factors for disease. Appl Clin Genet 4:11
Das R, Ghosh SK (2017) Genetic variants of the DNA repair genes from exome aggregation consortium (EXAC) database: significance in cancer. DNA Repair 52:92–102
Das R, Kundu S, Laskar S, Choudhury Y, Ghosh SK (2018) Assessment of DNA repair susceptibility genes identified by whole exome sequencing in head and neck cancer. DNA Repair 66:50–63
Flores M, Glusman G, Brogaard K, Price ND, Hood L (2013) P4 medicine: how systems medicine will transform the healthcare sector and society. Pers Med 10(6):565–576
Frydman G (2010) A patient-centric definition of participatory medicine. Available: https://participatorymedicine.org/epatients/2010/04/a-patient-centric-definition-of-participatory-medicine.html (accessed June 23, 2019)
Ghosh SK, Singh AS, Mondal R, Kapfo W, Khamo V, Singh YI (2014) Dysfunction of mitochondria due to environmental carcinogens in nasopharyngeal carcinoma in the ethnic group of northeast Indian population. Tumour Biol 35(7):6715–6724
Grange JM, Stanford JL, Stanford CA (2002) Campbell De Morgan's ‘observations on cancer’, and their relevance today. J R Soc Med 95(6):296–299
Hajdu SI (2011) A note from history: landmarks in history of cancer, part 2. Cancer 117(12):2811–2820
Hansa J, Kannan R, Ghosh SK (2012) Screening of 185DelAG, 1014DelGT and 3889DelAG BRCA1 mutations in breast cancer patients from north-East India. Asian Pac J Cancer Prev 13(11):5871–5874
Hansa J, Ghosh SK, Agrawala SK, Kashyap MP (2015) Risk and frequency of mutations in the BRCA1 in relation to GSTM1 and GSTT1 genotypes in breast cancer. Adv Biores 6:86–89
Hejmadi, M. (2009) Introduction to cancer biology, Bookboon [online], available: https://bookboon.com/en/introduction-to-cancer-biology-ebook (accessed February 16, 2020)
Hochberg ME, Thomas F, Assenat E, Hibner U (2013) Preventive evolutionary medicine of cancers. Evol Appl 6(1):134–143
Jen MY, Varacallo M (2020) Predictive medicine. In: StatPearls, Treasure Island (FL)
Kasahara Y, Tsukada Y (2004) New insights and future advances in cancer diagnostics. In: Cancer diagnostics. Humana Press, Totowa, NJ, pp 15–26
Katoch V (2016) Three-year report of population based cancer registries 2012–2014. National Cancer Registry Program, Indian Council of Medical Research, Bengaluru, India
Kaur, T., Babu, G., Sirohi, B., 2017. Consensus document for management of oesophageal cancer. Available: https://www.icmr.nic.in/sites/default/files/reports/Oesophageal%20Cancer.pdf (accessed February 16, 2020)
Khodakov D, Wang C, Zhang DY (2016) Diagnostics based on nucleic acid sequence variant profiling: PCR, hybridisation, and NGS approaches. Adv Drug Deliv Rev 105:3–19
Krishnatreya M, Kataki A (2016) A way forward to address the cancer burden in north-East India. Int J Health Allied Sci 5(1):61–61
Kumar M, Srivastava S, Singh SA, Das AK, Das GC, Dhar B, Ghosh SK, Mondal R (2017) Cell-free mitochondrial DNA copy number variation in head and neck squamous cell carcinoma: a study of non-invasive biomarker from Northeast India. Tumour Biol 39(10):1010428317736643
Kumar M, Choudhury Y, Ghosh SK, Mondal R (2018) Application and optimisation of minimally invasive cell-free DNA techniques in oncogenomics. Tumour Biol 40(2):1010428318760342
Kundu S, Ramshankar V, Verma AK, Thangaraj SV, Krishnamurthy A, Kumar R, Kannan R, Ghosh SK (2018) Association of DFNA5, SYK, and NELL1 variants along with HPV infection in oral cancer among the prolonged tobacco-chewers. Tumour Biol 40(8):1010428318793023
Lamb YN, Scott LJ (2017) Osimertinib: a review in T790M-positive advanced non-small cell lung cancer. Target Oncol 12(4):555–562
Laskar RS, Talukdar FR, Mondal R, Kannan R, Ghosh SK (2014) High frequency of young age rectal cancer in a tertiary care Centre of southern Assam, north East India. Indian J Med Res 139(2):314–318
Laskar RS, Ghosh SK, Talukdar FR (2015a) Rectal cancer profiling identifies distinct subtypes in India based on age at onset, genetic, epigenetic and clinicopathological characteristics. Mol Carcinog 54(12):1786–1795
Laskar RS, Talukdar FR, Choudhury JH, Singh SA, Kundu S, Dhar B, Mondal R, Ghosh SK (2015b) Association of HPV with genetic and epigenetic alterations in colorectal adenocarcinoma from Indian population. Tumour Biol 36(6):4661–4670
MacConaill LE, Garraway LA (2010) Clinical implications of the cancer genome. J Clin Oncol 28(35):5219
Mao L, Hong WK, Papadimitrakopoulou VA (2004) Focus on head and neck cancer. Cancer Cell 5(4):311–316
Mondal R, Ghosh SK (2013a) Accumulation of mutations over the complete mitochondrial genome in tobacco-related oral cancer from Northeast India. Mitochondrial DNA 24(4):432–439
Mondal R, Ghosh SK (2013b) HPV infection, GSTM 1-GSTT 1 genotypes , mitochondrial mutations and tobacco association with oral cancer from Northeast India. Head Neck Oncol 5(4):46
Mondal R, Ghosh SK, Choudhury JH, Seram A, Sinha K, Hussain M, Laskar RS, Rabha B, Dey P, Ganguli S, NathChoudhury M (2013a) Mitochondrial DNA copy number and risk of oral cancer: a report from Northeast India. PLoS One 8(3):e57771
Mondal R, Ghosh SK, Talukdar FR, Laskar RS (2013b) Association of mitochondrial D-loop mutations with GSTM1 and GSTT1 polymorphisms in oral carcinoma: a case control study from Northeast India. Oral Oncol 49(4):345–353
NCI (2018) ‘Cancer Statistics’, [online], Available: http://www.cancer.gov/about-cancer/what-is-cancer/statistics (Accessed January 10, 2019)
Paperna T, Staun-Ram E, Avidan N, Lejbkowicz I, Miller A (2016) Chapter 26: Personalised medicine and Theranostics: applications to multiple sclerosis. In: Arnon R, Miller A (eds) Translational Neuroimmunology in multiple sclerosis. Academic Press, San Diego, pp 387–414
Parsa N (2012) Environmental factors inducing human cancers. Iran J Public Health 41(11):1–9
Poste G (2001) Molecular diagnostics: a powerful new component of the healthcare value chain. Expert Rev Mol Diagn 1(1):1–5
Prainsack B (2014) The powers of participatory medicine. PLoS Biol 12(4):e1001837
ReferralMD 2018. The future role of precision medicine in cancer treatment. Available: https://getreferralmd.com/2018/05/the-future-role-of-precision-medicine-in-cancer-treatment/ [accessed June 23, 2019]
Riaz N, Morris LG, Lee W, Chan TA (2014) Unravelling the molecular genetics of head and neck cancer through genome-wide approaches. Genes Dis 1(1):75–86
Samarasam I (2017) Oesophageal cancer in India: current status and future perspectives. Int J Adv Med Health Res 4(1):5–10
Schutte AE (2017) Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the global burden of disease study 2016. Lancet 390(10100):1151–1210
Sharma D, Singh G (2017) Clinico-pathological profile of colorectal cancer in first two decades of life: a retrospective analysis from tertiary health Centre. Indian J Cancer 54(2):397–400
Singh SA, Ghosh SK (2014) Association of Epstein Barr virus and lifestyle on nasopharyngeal cancer risk among the ethnic population of Northeast India. Sci Technol J 2(2):95–102
Singh SA, Ghosh SK (2016) Polymorphisms of XRCC1 and XRCC2 DNA repair genes and interaction with environmental factors influence the risk of nasopharyngeal carcinoma in Northeast India. Asian Pac J Cancer Prev 17(6):2811–2819
Singh SA, Ghosh SK (2019) Metabolic phase I (CYPs) and phase II (GSTs) gene polymorphisms and their interaction with environmental factors in nasopharyngeal cancer from the ethnic population of Northeast India. Pathol Oncol Res 25(1):33–44
Sokolenko AP, Imyanitov EN (2018) Molecular diagnostics in clinical oncology. Front Mol Biosci 5:76
Sudhakar A (2009) History of cancer, ancient and modern treatment methods. J Cancer Sci Ther 1(2):1–4
Tabin CJ, Bradley SM, Bargmann CI, Weinberg RA, Papageorge AG, Scolnick EM, Dhar R, Lowy DR, Chang EH (1982) Mechanism of activation of a human oncogene. Nature 300(5888):143–149
Talukdar FR, Ghosh SK, Laskar RS, Mondal R (2013) Epigenetic, genetic and environmental interactions in oesophageal squamous cell carcinoma from Northeast India. PLoS ONE 8(4):e60996
Talukdar FR, Ghosh SK, Laskar RS, Kannan R, Choudhury B, Bhowmik A (2015) Epigenetic pathogenesis of human papillomavirus in upper aerodigestive tract cancers. Mol Carcinog 54(11):1387–1396
Tuljapurkar V, Dhar H, Mishra A, Chakraborti S, Chaturvedi P, Pai PS (2016) The Indian scenario of head and neck oncology–challenging the dogmas. South Asian J Cancer 5(3):105
Verma M (2014) Molecular profiling and companion diagnostics: where is personalised medicine in cancer heading? Pers Med 11(8):761–771
Warnakulasuriya S (2009) Global epidemiology of oral and oropharyngeal cancer. Oral Oncol 45(4–5):309–316
Acknowledgements
The authors are grateful to Silchar Medical College and Hospital (SMCH) and Cachar Cancer Hospital and Research Centre (CCHRC), Assam, for issuing tissue and blood samples of the patients. They are also appreciative to the Department of Biotechnology (DBT), Government of India for supporting infrastructural facilities and Department of Science and Technology (DST), Government of India as well as University Grant Commission (UGC), Government of India for providing fellowships under the DST-INSPIRE and UGC-MANF scheme, respectively.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Appendix
Appendix
Adenocarcinoma: It is cancer form that arises in the mucus-secreting glands of the body. It develops in different places, with most prevalent in the lung, resulting in lung cancer. Adenocarcinoma is the most common type of Non-small Cell Lung Cancer (NSCLC) which accounts for 80% of lung cancers.
Intronic variant: The introns are non-coding regions of an RNA transcript, which are removed by splicing before translation. Any type of variations in introns might affect alternative splicing of the mRNA as they are integral to gene expression regulation.
Mesenchymal cells: These are adult stem cells multipotent stromal in nature, which can differentiate into a various cell types such as chondrocytes (cartilage cells), osteoblasts (bone cells), adipocytes (fat cells), and myocytes (muscle cells).
Next-generation sequencing (NGS): It is a powerful platform enabling the sequencing of thousands to millions of DNA molecules simultaneously at high speed and at low cost. Various applications include whole genome sequencing, whole exome sequencing, study of genomic diversity, metagenomics, epigenetics, finding of non-coding RNAs and protein-binding sites, and RNA sequencing for gene-expression profiling.
Oligonucleotide microarrays: It is also normally known as DNA chip or biochip consisting of an assembly of microscopic DNA points, which remains attached to its solid surface. It is used to quantify the expression levels of huge numbers of genes at the same time and also to genotype numerous regions of a genome. It is generated either by in situ synthesis or deposition of pre-synthesized oligonucleotides ranging in size from 25- to 60-mers.
Pluripotent cells: Pluripotent stem cells, also known as human embryonic stem cells, have the potential to go through self-renewal and to create all cells of the tissues of the body. It can be applied to counter a wide range of diseases, from diabetes to spinal cord injury, to childhood leukaemia, to heart disease.
Squamous Cell Carcinoma (SCC): This type of cancer is caused by an uncontrolled growth of abnormal squamous cells. It comprises a number of different types of cancer and was found that about 90% of cases of HNC (cancer of the mouth, throat, nasopharynx, nasal cavity, and associated structures) are caused by SCC.
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Kundu, S., Das, R., Laskar, S., Choudhury, Y., Ghosh, S.K. (2022). Cancer Genomics and Diagnostics: Northeast Indian Scenario. In: Basu, S.K., Panda, C.K., Goswami, S. (eds) Cancer Diagnostics and Therapeutics . Springer, Singapore. https://doi.org/10.1007/978-981-16-4752-9_24
Download citation
DOI: https://doi.org/10.1007/978-981-16-4752-9_24
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-16-4751-2
Online ISBN: 978-981-16-4752-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)